This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Metsera, one of the few biotechs to complete an IPO this year, is making its bes...
President Donald Trump’s threatened tariffs on pharmaceuticals are incentivizing...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...
A penny stock biotech reported that its acute graft-versus-host disease drug fai...
My latest story is one I don’t get the chance to write often — maybe ever. W...
Plus, news about Bicycle Therapeutics, Kelso Pharma, Arbutus Biopharma, Ascletis...
The Department of Health and Human Services on Thursday announced major plans to...
Last year, Miga Health, a virtual cardiovascular care company, told investors it...
Despite cutting down on burnout, AI scribes have yet to clearly prove they save ...
Candel Therapeutics said Wednesday that its viral immunotherapy prolonged surviv...
A Miami startup looking to sequence the genetic diversity of 10 million people t...
Eye giant Alcon said Wednesday it acquired a majority stake in cell therapy star...
The FDA on Wednesday approved Soleno Therapeutics' new drug designed to treat th...
The FDA is taking issue with a promotional website from Taiho Oncology, alleging...
The FDA has approved Exelixis' cancer drug Cabometyx to treat advanced neuroendo...
Plenty of companies and CEOs have made the pilgrimage to Donald Trump's Mar-a-La...